Yonsei Med J.  2010 Jan;51(1):138-140. 10.3349/ymj.2010.51.1.138.

A Case of Pathologic Splenic Rupture as the Initial Manifestation of Acute Myeloid Leukemia M2

Affiliations
  • 1Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. kimhj@dau.ac.kr
  • 2Department of Pathology, Dong-A University College of Medicine, Busan, Korea.
  • 3Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea.
  • 4Department of Surgery, Dong-A University College of Medicine, Busan, Korea.

Abstract

A pathologic splenic rupture refers to a rupture without trauma. A splenic rupture as the initial manifestation of acute myeloid leukemia is extremely rare. In this study, we described a rare case of acute myeloid leukemia presenting principally as an acute abdomen due to a pathologic splenic rupture in a 35-year old male patient. We can assert that a pathologic splenic rupture in hematologic diseases is a potentially life-threatening complication, which necessitates immediate operative intervention. Any such patient complaining about left upper abdominal tenderness should be closely observed, and further diagnostic investigations (ultrasonograph of the abdomen, abdominal CT scan) should be initiated in order to rule out a splenic rupture. The oncologist should be aware of this rare initial presentation of acute myeloid leukemia (AML) M2, as the condition generally necessitates a prompt splenectomy.

Keyword

Acute myeloid leukemia M2; pathologic; splenic rupture

MeSH Terms

Adult
Humans
Leukemia, Myeloid, Acute/*diagnosis/pathology/radiography
Male
Splenic Rupture/*diagnosis/pathology/radiography
Tomography, X-Ray Computed

Figure

  • Fig. 1 Computed tomography (CT) image of the upper abdomen demonstrates multiple splenic lacerations evidenced by the irregular, nonhomogeneous, low density of splenic body (red arrows).

  • Fig. 2 (A) The spleen shows blood clots attached to the ruptured capsule (H-E stain, ×20). (B) The spleen evidences diffuse invasion by immature myeloid cells (H-E stain, ×200). (C) The infiltrates are composed principally of myeloperoxidase-positive immature myeloid cells (Myeloperoxidase stain, ×400).

  • Fig. 3 (A) This section shows hypercellular marrow with a cellularity of 70-80% and a diffuse infiltration of leukemic blasts (H-E stain, ×400). (B) Leukemic blasts tested positive for myeloperoxidase (Myeloperoxidase stain, ×1,000). (C) Leukemic blasts tested positive for PAS (PAS stain, ×1,000).


Reference

1. Giagounidis AA, Burk M, Meckenstock G, Koch AJ, Schneider W. Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann Hematol. 1996. 73:297–302.
Article
2. Bernat S, García Boyero R, Guinot M, López F, Gozalbo T, Cañ igral G. Pathologic rupture of the spleen as the initial manifestation in acute lymphoblastic leukemia. Haematologica. 1998. 83:760–761.
3. Görg C, Barth P, Weide R, Schwerk WB. Spontaneous splenic rupture in acute myeloid leukemia: sonographic follow-up study. Bildgebung. 1994. 61:37–39.
4. Wong P, Takabayashi K, Sugiura Y, Asai T, Itoh K, Yoshida S, et al. Splenic rupture in acute megakaryoblastic leukemia. Jpn J Med. 1987. 26:234–236.
5. Rajagopal A, Ramasamy R, Martin J, Kumar P. Acute myeloid leukemia presenting as splenic rupture. J Assoc Physicians India. 2002. 50:1435–1437.
6. Pastore D, Specchia G, Carluccio P, Liso A, Mestice A, Rizzi R, et al. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Ann Hematol. 2003. 82:231–235.
Article
7. Goddard SL, Chesney AE, Reis MD, Ghorab Z, Brzozowski M, Wright FC, et al. Pathological splenic rupture: a rare complication of chronic myelomonocytic leukemia. Am J Hematol. 2007. 82:405–408.
Article
8. Athale UH, Kaste SC, Bodner SM, Ribeiro RC. Splenic rupture in children with hematologic malignancies. Cancer. 2000. 88:480–490.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr